Breaking News, Promotions & Moves

Biogen Idec

Paul Clancy has been appointed executive vice president and chief financial officer, Biogen Idec. He reports to James C. Mullen, the company’s chief executive officer, and most recently served as senior vice president of finance, responsible for leading the treasury, tax, investor relations and business planning groups.

“Paul brings more than 20 years of experience in financial management and strategic business planning,” Mr. Mullen said. “In his six years at Biogen Idec, he has repeatedly proven himself to be an effective and valued leader. With Paul’s help, we will continue to optimize shareholder value by driving our strategic and operational plans.”

Mr. Clancy has held several senior executive positions since joining the company in 2001, including vice president of business planning, portfolio management and U.S. marketing. Prior to joining the company, he spent 13 years at PepsiCo, serving in a range of financial and general management positions.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters